|
Study, year | Country | Total number | HIV+/HCV+ number | Control Group(s) | Age (yrs) HIV+/HCV+ | Study design | Population study/setting | Topics |
|
Mandorfer et al., 2015 [34] | USA | 86 | 86 | | 38.7 median | Cohort retrospective | HIV/HCV coinfected | Vitamin D levels. Other variables and severity of liver disease |
|
Dong et al., 2014 [22] | USA | | | | | Systematic review and meta-analysis | HIV/HCV coinfected | Osteoporosis and fractures |
|
Guzmán-Fulgencio et al., 2014 [31] | Spain | 174 | 174 | HIV/HCV coinfection | 40.8 median | Cross-sectional | HIV/HCV coinfected | Prevalence of vitamin D levels and association with other parameters |
|
Avihingsanon et al., 2014 [32] | Australia | 331 | 130 | Monoinfected HCV− HIV/HCV coinfection | 42 median | Cross-sectional | HIV/HCV coinfected | Vitamin D levels and virological response in coinfection treatment |
|
Luetkemeyer et al., 2013 [20] | USA | | | | | Review | monoinfected HIV and HIV/HCV coinfected | Bone metabolisms and vitamin D deficiency |
|
Mandorfer et al., 2013 [35] | Austria | 65 | 65 | HIV/HCV coinfection | 38.6 median | Cross-sectional | HIV/HCV coinfected | Vitamin D levels and virological response in coinfection treatment |
|
Branch et al., 2013 [36] | USA | 144 | 144 | non-EVR* HIV/HCV coinfected | 48 median | Cohort retrospective | HIV/HCV coinfected genotype 1 treated in ACTG study | Vitamin D levels and virological response in coinfection treatment |
|
El-Maouche et al., 2013 [33] | USA | 116 | 116 | HIV/HCV coinfection | 49.9 median | Cohort prospective | HIV/HCV coinfected | Vitamin D levels and bone mineral density (BMD) |
|
Linari et al., 2013 [37] | Italy | 78 | 26 | Monoinfected (HIV+)/Uninfected | 45.8 mean | Cross-sectional | Haemophilia | Prevalence of hypovitaminosis D and BMD markers |
|
Maalouf et al., 2013 [21] | USA | 56.660 | 17.734 | Monoinfected (HIV+) | 44 median | Cohort retrospective | HIV-infected population | HCV-associated risk of osteoporotic fractures and severity of liver disease |
|
Vecchi et al., 2012 [38] | Italy | 120 | 41 | Monoinfected (HIV+)/Uninfected | 47 mean | Cohort prospective | HIV-infected population | Vitamin D levels and BMD; dairy calcium intake |
|
Milazzo et al., 2011 [39] | Italy | 237 | 93 | Monoinfected HIV/Uninfected | 45 median | Cross-sectional | HIV-infected population | Vitamin D levels and severity of liver disease |
|